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Detection of Anionic Antimicrobial Peptides in Ovine Bronchoalveolar
Lavage Fluid and Respiratory Epithelium
Abstract
Three small antimicrobial anionic peptides (AP) were originally isolated from an ovine pulmonary surfactant.
However, their presence in bronchoalveolar lavage (BAL) fluid and tissues of the respiratory tract is unknown.
In this study, we made affinity-purified rabbit polyclonal and mouse monoclonal antibodies to synthetic H-
DDDDDDD-OH. Antibody specificity was assessed by a competitive enzyme-linked immunosorbent assay
(ELISA), and the exact epitope binding sites were determined with analog peptides synthesized on
derivatized cellulose. These antibodies were used to detect AP in BAL fluid by ELISA and in respiratory
tissues by Western blot analysis and immunocytochemistry. BAL fluid from 25 sheep contained 0.83 ± 0.33
mM AP (mean ± standard deviation; range, 0.10 to 1.59 mM) and was antimicrobial. The presence of AP in
BAL fluid was confirmed by reverse-phase high-pressure liquid chromatography fractionation followed by
matrix-assisted laser desorption/ionization (MALDI) mass spectrometry on those fractions which were
positive by competitive ELISA and demonstrated antimicrobial activity. In Western blots, polyclonal antibody
PAB96-1 and monoclonal antibody 1G9-1C2 (5.0 μg/ml) detected four bands in solubilized turbinate and
tracheal epithelial cells (53.7, 31.2, 28.0, and 25.7 kDa) and five bands in lung homogenates (53.5, 37.1, 31.2,
28.0, and 25.7 kDa). Only a single band was seen in solubilized liver and small-intestine homogenates, and no
bands were seen in blots containing BAL fluid, albumin, or kidney or spleen homogenates. In pulmonary-
tissue sections, both antibodies PAB96-1 and 1G9-1C2 identified accumulated protein in the apical
cytoplasm of the bronchial and bronchiolar epithelia, in the cytoplasm of pulmonary endothelial cells, and in
an occasional alveolar macrophage. As a first step in identifying a candidate AP precursor gene(s), degenerate
oligonucleotides representing all possible coding combinations for H-GADDDDD-OH and H-DDDDDDD-
OH were synthesized and used to probe Southern blots of sheep genomic DNA. Following low-stringency
washes and a 2-day exposure, strongly hybridizing bands could be identified. One degenerate oligonucleotide,
SH87, was used as a hybridization probe to screen a sheep phage genomic library. Two independent phage
contained the H-GADDDDD-OH coding sequence as part of a larger predicted protein. AP may originate as
part of an intracellular precursor protein, with multistep processing leading to the release of the heptapeptide
into mucosal secretions. There it may interact with other innate pulmonary defenses to prevent microbial
infection.
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Three small antimicrobial anionic peptides (AP) were originally isolated from an ovine pulmonary surfac-
tant. However, their presence in bronchoalveolar lavage (BAL) fluid and tissues of the respiratory tract is
unknown. In this study, we made affinity-purified rabbit polyclonal and mouse monoclonal antibodies to
synthetic H-DDDDDDD-OH. Antibody specificity was assessed by a competitive enzyme-linked immunosorbent
assay (ELISA), and the exact epitope binding sites were determined with analog peptides synthesized on
derivatized cellulose. These antibodies were used to detect AP in BAL fluid by ELISA and in respiratory tissues
by Western blot analysis and immunocytochemistry. BAL fluid from 25 sheep contained 0.83 6 0.33 mM AP
(mean 6 standard deviation; range, 0.10 to 1.59 mM) and was antimicrobial. The presence of AP in BAL fluid
was confirmed by reverse-phase high-pressure liquid chromatography fractionation followed by matrix-as-
sisted laser desorption/ionization (MALDI) mass spectrometry on those fractions which were positive by
competitive ELISA and demonstrated antimicrobial activity. In Western blots, polyclonal antibody PAB96-1
and monoclonal antibody 1G9-1C2 (5.0 mg/ml) detected four bands in solubilized turbinate and tracheal
epithelial cells (53.7, 31.2, 28.0, and 25.7 kDa) and five bands in lung homogenates (53.5, 37.1, 31.2, 28.0, and
25.7 kDa). Only a single band was seen in solubilized liver and small-intestine homogenates, and no bands were
seen in blots containing BAL fluid, albumin, or kidney or spleen homogenates. In pulmonary-tissue sections,
both antibodies PAB96-1 and 1G9-1C2 identified accumulated protein in the apical cytoplasm of the bronchial
and bronchiolar epithelia, in the cytoplasm of pulmonary endothelial cells, and in an occasional alveolar
macrophage. As a first step in identifying a candidate AP precursor gene(s), degenerate oligonucleotides
representing all possible coding combinations for H-GADDDDD-OH and H-DDDDDDD-OH were synthesized
and used to probe Southern blots of sheep genomic DNA. Following low-stringency washes and a 2-day
exposure, strongly hybridizing bands could be identified. One degenerate oligonucleotide, SH87, was used as
a hybridization probe to screen a sheep phage genomic library. Two independent phage contained the H-
GADDDDD-OH coding sequence as part of a larger predicted protein. AP may originate as part of an
intracellular precursor protein, with multistep processing leading to the release of the heptapeptide into
mucosal secretions. There it may interact with other innate pulmonary defenses to prevent microbial infection.
Inhaled air and aspirated aerosols of upper-respiratory se-
cretions contain large quantities of microorganisms, often ap-
proaching 108 to 109 bacteria per ml (1). Despite the con-
tinuous exposure to both environmental and commensal
organisms, the respiratory tract remains remarkably free from
infections. Innate pulmonary immunity is generally thought to
be provided by overlapping mechanical, chemical, and cell-
mediated clearance mechanisms (16). Recent evidence sug-
gests that antimicrobial peptides play an integral role in pro-
tection of the respiratory tree (17). Examples include both
cationic defensins (10, 13) and anionic peptides (AP) (8, 12),
isolated from epithelial cells and from pulmonary secretions,
respectively. Overall, these peptides have broad-spectrum ac-
tivity against both gram-positive and gram-negative bacteria (3,
7, 9).
Ovine AP were isolated originally from a pulmonary surfac-
tant (and are called surfactant-associated AP) (6). The bio-
chemical features and requirements for antimicrobial activity
were similar to those of the partially purified peptides found in
mouse, rabbit, and human bronchoalveolar lavage (BAL) fluid
(8, 12). Ovine AP are small (721.6 to 823.7 Da) and hydrophilic
and contain homopolymeric regions (e.g., 5 to 7 residues) of
aspartic acid (6). MICs of AP and similar analogs (4) are
comparable to those of other vertebrate antimicrobial peptides
(3, 7, 9).
The biochemistry and localization of AP synthesis remain to
be characterized. In this study, we used both polyclonal and
monoclonal antibodies generated against the synthetic peptide
H-DDDDDDD-OH to detect and quantify the level of AP in
BAL fluid, to localize sites of AP expression within the lung,
and to identify putative AP precursor proteins.
MATERIALS AND METHODS
Animals. Seven Columbia sheep, weighing 60 to 80 kg each, were bled, eu-
thanized (with sodium pentobarbital at 60 mg/kg of body weight), and exsangui-
nated in accordance with procedures outlined by the American Association for
Accreditation of Laboratory Animal Care and the Institutional Animal Care and
Use Committee of the National Animal Disease Center. In addition, excised
lungs were obtained from 20 lambs at a local slaughter plant.
* Corresponding author. Mailing address: Respiratory and Neuro-
logic Disease Research Unit, National Animal Disease Center, Agri-
cultural Research Service, U.S. Department of Agriculture, P.O. Box
70, Ames, IA 50010. Phone: (515) 239-8593. Fax: (515) 239-8458.
E-mail: kbrogden@nadc.ars.usda.gov.
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BAL. The lungs of the seven sheep were excised and lavaged to total lung
capacity with 5 liters of 0.14 M NaCl. The lungs of the 20 lambs from the
slaughter plant were lavaged to total lung capacity with 0.14 M NaCl, and an
effluent lavage volume of 1 liter was collected. The BAL fluids from all sheep
were centrifuged at 200 3 g for 30 min at 4°C to remove alveolar cells and
residual debris. Blood urea nitrogen concentrations (1.3 6 0.5 mg/dl) (mean 6
standard deviation [SD]) were determined (Clinical Pathology Laboratory, Col-
lege of Veterinary Medicine, Iowa State University, Ames) and used to calculate
the epithelial lining fluid (ELF) volume in each BAL fluid sample (15). BAL
fluid was then adjusted to contain 0.5 ml of ELF/liter of BAL fluid for a
comparative assessment of AP concentration among animals.
Peptide synthesis. Peptides H-DDDDDDD-OH, H-GADDDDD-OH,
H-GDDDDDD-OH, and H-VDDDDK-OH were synthesized by Multiple Pep-
tide Systems (San Diego, Calif.) by using Merrifield resins and standard tert-
butoxycarbonyl chemistry in combination with simultaneous multiple-peptide
synthesis (SMPS or “tea-bag” methodology). Cyclohexyl was used as a side
chain-protecting group for aspartic acid. H-TQDDGGK-OH, H-GGEEK-OH,
and H-SGSGSGS-OH were synthesized by Chiron Mimotopes Pty. Ltd. (Aus-
tralia) on a grafted polymer surface in a Multipin peptide synthesis format with
N-a-9-fluorenylmethoxycarbonyl-protected amino acids. The peptides were side
chain deprotected and cleaved from the solid support by acidolysis. Peptides
were purified by high-pressure liquid chromatography (HPLC), characterized by
analytical HPLC and by plasma desorption mass spectral analysis on a Biolon 20
Mass Analyzer, and lyophilized. Peptides were 95 to 99% pure and were verified
by amino acid analysis.
Antibody. The a-amino group of H-DDDDDDD-OH (5.0 mg) was coupled to
5.0 mg of keyhole limpet hemocyanin with glutaraldehyde and used as an antigen
to immunize both rabbits and mice. To immunize rabbits (9-month-old New
Zealand rabbits), the conjugate was suspended in 10 mM sodium phosphate
buffer (pH 7.2) with 140 mM NaCl (PBS) (3.1 mg/ml), emulsified in Freund’s
adjuvant (50% emulsion; total volume of 0.6 ml), and injected into four subcu-
taneous dorsal sites. Subsequent immunizations (days 14, 42, and 56 post-initial
immunization) utilized the same conjugate, substituting incomplete Freund’s
adjuvant. Antiserum was collected on day 70. Antibody (PAB96-1) was affinity
purified on a gel prepared by coupling H-DDDDDDD-OH (3 mg) through the
N-terminal amino group to aldehyde-activated agarose (3 ml). Bound antibody
was eluted with 0.1 M glycine-HCl buffer (pH 2.7), neutralized with Tris buffer,
assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE), and adjusted to contain 0.1 mg of protein/ml.
To immunize CF1 mice, 0.25 ml of conjugate (1.0 mg/ml), 0.125 ml of PBS, and
0.125 ml of muramyl dipeptide (1.0 mg/ml) were emulsified in 0.5 ml of incom-
plete Freund’s adjuvant (50% emulsion; total volume of 1.0 ml) and injected
subcutaneously (0.2 ml). After 20 days, the mice were euthanized for removal of
their spleens. Spleen cells were fused with myeloma cells (Sp2/0 Ag 14 myeloma
cell line CRL1581; American Type Culture Collection, Manassas, Va.), and
hybrid cells were propagated and screened for antibody production by an en-
zyme-linked immunosorbent assay (ELISA) using H-DDDDDDD-OH conju-
gated to bovine serum albumin (BSA-DDDDDDD conjugate) as the antigen.
Two positive primary hybrids, 1G9-1C2 and 1G9-2B10, were then selected for
single-cell cloning. Monoclonal antibody in supernatants was then isolated on a
Protein A-Sepharose column (HiTrap; Pharmacia Biotech, Piscataway, N.J.).
Bound antibody was eluted with 0.1 M glycine-HCl buffer (pH 2.7), neutral-
ized with Tris buffer, and assessed by SDS-PAGE. 1G9-1C2 was adjusted to a
stock solution of 1.0 mg of protein/ml, and 1G9-2B10 contained 0.586 mg of
protein/ml.
Assessment of antibody specificity. Antibody specificity was assessed by a
competitive ELISA. BSA-DDDDDDD-OH conjugate (50 ng of conjugate/well)
was used as the adsorbed antigen, and varying graded concentrations (1.0 to
0.002 mM) of H-DDDDDDD-OH, H-GADDDDD-OH, H-VDDDDK-OH, H-
TQDDGGK-OH, H-GGEEK-OH, and H-SGSGSGS-OH were used as the com-
petitive antigens in the presence of antibody PAB96-1, 1G9-1C2, or 1G9-2B10
(1.0 mg/ml).
The epitope binding sites of the three antibodies were also determined. Thirty
peptides (7 residues each) corresponding to a single-residue frameshift of the
sequence in Fig. 3 were synthesized simultaneously on a derivatized cellulose
sheet (SPOTs; Genosys, The Woodlands, Tex.). For example, peptide 1, starting
at residue 30 of AP 87-8, was H-DDGDDDG-OH, peptide 2 was H-DGD
DDGA-OH, peptide 3 was H-GDDDGAD-OH, etc. SPOT 32 contained H-
DDDDDDD-OH and SPOT 33 contained H-EEEEEEE-OH as peptide con-
trols. The strip was incubated overnight in casein-based blocking buffer (Geno-
sys), washed in 0.05 M Tris buffer (pH 8.0) with 0.14 M NaCl, 2.7 mM KCl, and
0.05% Tween 20 (T-TBS), and incubated in casein-based blocking buffer con-
taining antibody for 3 h at room temperature. Preimmunized rabbit serum (1:40),
preimmunized mouse serum (1:40), rabbit antibody PAB96-1 (5 and 25 mg/ml),
mouse antibodies 1G9-2B10 and 1G9-1C2 (5 and 25 mg/ml), secondary b-galac-
tosidase-conjugated sheep polyclonal antibody to mouse immunoglobulin G
(IgG) (5 mg/ml), and secondary b-galactosidase-conjugated sheep polyclonal
antibody to rabbit IgG (5 mg/ml) were all tested. After incubation, the membrane
was washed in T-TBS and incubated in secondary b-galactosidase-conjugated
sheep polyclonal antibody to rabbit or mouse IgG (5 mg/ml) for 2 h at room
temperature. Bound antibody was detected with Signal Development solution
(Genosys).
ELISA. The concentration of AP in BAL fluids was assessed by a direct
ELISA. Briefly, samples (100 ml) were incubated overnight at 26°C in styrene
plates (Immulon 1; Dynatech Laboratories, Inc., Chantilly, Va.). The negative
control was a surfactant from sheep 3149 (100 ml), previously shown not to be
bactericidal (6). The positive control was synthetic peptide H-DDDDDDD-OH
added to a surfactant (1.0 to 0.063 mM). Wells were blocked with gelatin
blocking buffer. Antibody PAB96-1 or 1G9-1C2 (1.0 mg/ml of blocking buffer)
was added and incubated for 1 h. The wells were washed, and antibody was
detected with peroxidase-labeled goat anti-rabbit IgG or goat anti-mouse IgG
(Kirkegaard & Perry Laboratories, Inc., Gaithersburg, Md.), respectively. Anti-
body binding reactions were detected with tetramethylbenzidine (TMB substrate
and stop system; Kirkegaard & Perry Laboratories, Inc.).
The competitive ELISA was also used to find AP in reverse-phase (RP) HPLC
fractions of BAL fluid and epithelial-cell extracts. BSA-DDDDDDD-OH con-
jugate (50 ng of conjugate/well) was used as the adsorbed antigen, varying graded
concentrations (1.0 to 0.002 mM) of H-DDDDDDD-OH were used as the
competitive control antigen, and column fractions were used as the competitive
FIG. 1. The competitive ELISA was used to assess the specificity of monoclonal antibody 1G9-1C2. BSA-DDDDDDD-OH conjugate (50 ng of conjugate/well) was
used as the adsorbed antigen, and varying graded concentrations (1.0 to 0.002 mM) of H-DDDDDDD-OH (peptide 1), H-GADDDDD-OH (peptide 2), H-
TQDDGGK-OH (peptide 3), H-GGEEK-OH (peptide 4), H-VDDDDK-OH (peptide 5), and H-SGSGSGS-OH (peptide 6) were used as the competitive antigens in
the presence of antibody 1G9-1C2 (1.0 mg/ml). Antibody 1G9-1C2 was specific and recognized H-GADDDDD-OH nearly as well as H-DDDDDDD-OH. However,
the sequences with internal Asp or Glu residues (e.g., H-VDDDDK-OH, H-TQDDGGK-OH, and H-GGEEK-OH) were not recognized and did not cross-react.
H-SGSGSGS-OH was a negative-control peptide.
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antigens in the presence of antibody PAB96-1, 1G9-1C2, or 1G9-2B10 (1.0
mg/ml).
Identification of AP genes. Degenerate oligonucleotides, representing
H-GADDDDD-OH (SH87, 59 GGTGCTGAYGAYGAYGAYGAY 39, where
Y stands for T or C) and H-DDDDDDD-OH (SH88, 59 GAYGAYGAYGAY
GAYGAYGAY 39, where Y stands for T or C) were synthesized, end labeled
with 32P, and used to probe a Southern blot containing sheep genomic DNA to
identify candidate AP precursor genes. Oligonucleotide SH87 was also used as a
hybridization probe to screen a sheep phage genomic library (Clonetech) by
standard techniques (11).
RP-HPLC. BAL fluid from each sheep (1.6 ml) and lysed tracheal epithelial-
cell extracts from two sheep (1.6 ml) were mixed with chloroform (2 ml) and
methanol (4 ml) to extract lipids as described by Bligh and Dyer (2). The
methanol-water phase was then removed and dried by rotary evaporation. The
residue was resuspended in distilled water and filtered, first in a sterilizing
centrifugal filter (Ultrafree-CL; 0.22 mm; Millipore Corp., Bedford, Mass.) and
then through a centrifugal ultrafilter (Biomax-10; Millipore Corp.). The 10-kDa
ultrafiltrate was collected and separated (50-ml aliquots) on a C18 column (Ju-
piter 300; 5-mm particle size; 4.6 by 250 mm; Phenomenex, Torrance, Calif.) by
using a 12114M pump and a 406 Analog Interface Module (Beckman Instru-
ments, Inc., Palo Alto, Calif.). Timed fractions over 30 min were eluted with a
gradient of acetonitrile (0 to 100%) in 0.1% trifluoroacetic acid (TFA) with a
flow rate of 1.0 ml/min. Fractions were collected (SC100 fraction collector;
Beckman Instruments, Inc.). Fractions were pooled with similar fractions of
previous runs and evaporated to dryness under a vacuum. Residues were dis-
solved in distilled water and tested for antimicrobial activity. Antimicrobial
fractions were separated again by HPLC and eluted in a 0 to 30% acetonitrile
gradient over 30 min with a flow rate of 0.5 ml/min. Fractions were collected,
evaporated to dryness, dissolved in distilled water, and again tested for antimi-
crobial activity, analyzed for amino acid content, or checked for peptide content
by ELISA. Synthetic peptides H-DDDDDDD-OH, H-GADDDDD-OH, and
H-GDDDDDD-OH were added to BAL fluid before sample preparation and
used as internal standard column controls.
Mass spectrometry. HPLC fractions with antimicrobial activity and evidence
of AP by competitive ELISA were examined for H-DDDDDDD-OH, H-GAD
DDDD-OH, H-GDDDDDD-OH, (M 1 H)1, (M 1 Na)1, or (M 1 K)1 masses
by matrix-assisted laser desorption/ionization (MALDI) (Finnigan MAT, Laser-
mat 2000; Protein Facility, Iowa State University). The matrix was a-cyano-4-
hydroxycinnamic acid (50%, vol/vol).
Antimicrobial activity. Pasteurella haemolytica serotype A1 strain 82-25, iso-
lated from a sheep with enzootic pneumonia, was grown in tryptose broth at 37°C
for 3 h, pelleted by centrifugation at 5,900 3 g for 15 min at 4°C, and resuspended
in 140 mM NaCl. The suspensions were adjusted in the spectrophotometer (78%
transmittance at 600 nm; Coleman model 35; Bacharach Instrument Co.) to
contain 1.0 3 108 CFU/ml and were diluted 1025-fold to 103 CFU/ml of 140 mM
NaCl (6). A dilution susceptibility test was used to obtain the percent killed
bacteria in BAL fluids compared to that in the control solution (4). Percent
killing was calculated as [1 2 (CFU in BAL fluids/CFU in saline control mix-
tures)] 3 100.
SDS-PAGE and Western blotting. BAL fluid, respiratory epithelial cells
(scraped from either turbinate or tracheal surfaces), and small pieces of tissue
(e.g., lung, liver, spleen, kidney, small intestine, and bladder wall) were ground in
Tenbrock tissue grinders, diluted 4:5 with sample buffer (ImmunoPure; Pierce,
Rockford, Ill.), and heated for 5 min at 100°C. Proteins in solubilized BAL fluid
and cell and tissue homogenates were then separated by SDS-PAGE (14) with a
6.0% stacking gel over a 12.5% resolving gel. Prestained and unstained protein
ladders (10 to 184 kDa; Benchmark; Life Technologies, Gaithersburg, Md.) were
FIG. 2. The epitope binding sites of antibody 1G9-1C2 (25 mg/ml) were
determined with 30 peptides (7 residues each) corresponding to a single-residue
frameshift of the 7-residue sequence starting at residue 30 of the sequence
identified in AP 87-8 of Fig. 3. For example, peptide 1 was H-DDGDDDG-OH,
peptide 2 was H-DGDDDGA-OH, peptide 3 was H-GDDDGAD-OH, etc. Pep-
tides were synthesized simultaneously on a derivatized cellulose sheet (SPOTs;
Genosys). SPOT 32 contained H-DDDDDDD-OH and SPOT 33 contained
H-EEEEEEE-OH as peptide controls. SPOTs were detected after the strip was
incubated in casein-based blocking buffer, incubated in antibody, washed, incu-
bated in secondary b-galactosidase-conjugated antibody, and incubated in Signal
Development solution. Epitopes that contained more than 2 terminal Asp resi-
dues were recognized.
FIG. 3. Nucleotide and predicted peptide sequences for candidate AP pre-
cursor genes, comprising exons from sheep genomic library clones. The predicted
ORF for AP 87-8 extends in the 59 direction. ORF sequences are capitalized, and
potential AP coding sequences are in boldface.
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used as standards. Proteins were blotted onto Immobilon-P transfer membranes
(Millipore Corp.) and cut into strips. One strip of each tissue blot was stained
with Coomassie blue, and the other strip was blocked overnight with gelatin
blocking buffer containing 10 mM Tris buffer, 145 mM NaCl, 1.0% fish gelatin,
and 0.05% Tween 20. Strips were incubated for 1 h with antibody PAB96-1 or
1G9-1C2 (5.0 mg/ml) and washed. Bound antibody was detected with peroxidase-
labeled goat anti-rabbit IgG or goat anti-mouse IgG (0.5 mg/ml; Kirkegaard &
Perry Laboratories, Inc.), respectively, and a 4-chloro-1-naphthol substrate sys-
tem (Kirkegaard & Perry Laboratories, Inc.). Blots were photographed (digital
camera RD-175; Minolta, Ramsey, N.J.), and the molecular masses of the reac-
tive bands were determined (GelCompar, v. 4.0; Applied Maths, Kortrijk, Bel-
gium) by extrapolation from a standard curve of the molecular masses of the
prestained bands on the protein ladder.
As controls, strips of membrane containing separated tracheal and lung pro-
teins were incubated with preimmunized rabbit serum (1:200), preimmunized
mouse serum (1:200), or peroxidase-labeled goat anti-rabbit IgG (0.5 mg/ml) or
goat anti-mouse IgG (0.5 mg/ml). No reactions were seen. In addition, preincu-
bation of antibody PAB96-1, 1G9-2B10, or 1G9-1C2 (5.0 mg/ml) with 1.0 mM
H-DDDDDDD-OH eliminated specific staining of all bands.
Histopathology and immunocytochemistry. Pulmonary tissue, taken from each
lung, was fixed in 10% neutral buffered formalin solution, dehydrated and
cleared, embedded in paraffin, sectioned, and stained with hematoxylin and
eosin.
Pulmonary tissues for immunocytochemical analysis for AP were sectioned
onto ProbeOn Plus microscope slides (Fisher Scientific, Pittsburgh, Pa.) as pre-
viously described (5). Paraffin was removed with xylene, and the ovine tissue
sections were rehydrated sequentially in 100% ethanol, 90% ethanol, and 70%
ethanol and then were rinsed in water. The sections were first incubated in a
gelatin blocking buffer and then digested with trypsin for 15 min at 37°C. After
an additional wash first in gelatin blocking buffer and then in blocking serum, the
FIG. 4. RP-HPLC chromatograms of ovine BAL fluid (A) and ovine epithelial-cell extracts (B), showing peak fraction 5, eluted in 13 to 14% acetonitrile, with
antimicrobial activity and evidence of AP by competitive ELISA with antibody 1G9-1C2. BSA-DDDDDDD-OH conjugate (50 ng of conjugate/well) was used as the
adsorbed antigen, and RP-HPLC fractions were used as the competitive antigens in the presence of antibody 1G9-1C2 (1.0 mg/ml). To confirm the presence of AP,
fractions were examined by MALDI mass spectrometry. H-DDDDDDD-OH [(M 1 H)1; 824.4 Da], H-GDDDDDD-OH [(M 1 H)1; 766.1 Da], and
H-GADDDDD-OH [(M 1 H)1; 718.24 Da] were detected.
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sections were incubated with antibody PAB96-1 (0.5 mg/ml) or 1G9-1C2 (2.0
mg/ml) for 1.5 h at 37°C. Sections were then washed in gelatin blocking buffer,
incubated with biotinylated goat anti-mouse or goat anti-rabbit antibody (Kirke-
gaard & Perry Laboratories, Inc.), respectively, washed in buffer, and incubated
in streptavidin-alkaline phosphatase for 30 min at room temperature. The color
was developed with HistoMark Red (Kirkegaard & Perry Laboratories, Inc.).
Sections were then counterstained with hematoxylin for 1 min (Shannon Lip-
shaw), dehydrated, infiltrated, and mounted.
The immunohistochemical procedure was optimized after a series of trials.
Control tissue sections were processed as described above without antibody
1G9-1C2 or with antibody 1G9-1C2 preincubated with 0.5 mM H-DDDDDDD-
OH. In both of these controls, staining specific for AP could not be detected.
Tissue sections were also incubated with trypsin for 15 or 30 min or heated in a
microwave for 10 min in either citrate buffer (pH 6.0; Biogenex) or Tris buffer
(pH 10.0) to further expose AP in cells. None of these treatments dramatically
increased staining specific for AP. Tissue sections were also incubated in a variety
of blocking buffer solutions, including solutions containing fish gelatin, 10, 50, or
100% normal goat serum, or fish gelatin with either 10, 50, or 100% normal goat
serum, or in a commercial blocker (Powerblock; Biogenex). Gelatin blocking
buffer containing 50% normal goat serum was chosen; it enhanced specificity as
well as reducing nonspecific background and nuclear staining.
RESULTS
Assessment of antibody specificity. Polyclonal antibody
PAB96-1 and monoclonal antibodies 1G9-1C2 and 1G9-2B10
were specific for peptides with C-terminal Asp residues (Fig. 1
and 2). In the competitive ELISA, all three antibodies reacted
similarly (results with antibody 1G9-1C2 are shown in Fig. 1,
and the results with antibodies PAB96-1 and 1G9-2B10 are not
shown). All antibodies recognized H-GADDDDD-OH nearly
as well as H-DDDDDDD-OH. However, H-VDDDDK-OH,
H-TQDDGGK-OH, H-GGEEK-OH, and H-SGSGSGS-OH
were not recognized and did not cross-react.
With the SPOTs Epitope Mapping Kit, the epitope binding
sites of antibodies PAB96-1, 1G9-1C2, and 1G9-2B10 were
determined with 30 peptides (7 residues each) corresponding
to a single-residue frameshift of the 7-residue sequence start-
ing at residue 30 of the sequence identified in AP 87-8 of Fig.
3. Antibody 1G9-1C2 (25 mg/ml only; Fig. 2) recognized
epitopes that contained more than 2 C-terminal Asp residues.
Antibody PAB96-1 (both 5 and 25 mg/ml), affinity purified on
a gel coupled with H-DDDDDDD-OH, recognized only H-
DDDDDDD-OH (data not shown). Antibody 1G9-2B10 (5
and 25 mg/ml) did not react with any epitope in this assay (data
not shown). As in the reactions with the SPOTs Epitope Map-
ping Kit, antibodies PAB96-1 and 1G9-1C2 worked well to
detect proteins by Western blot, but 1G9-2B10 did not. Pre-
immunized rabbit serum (1:40), preimmunized mouse serum
(1:40), and secondary b-galactosidase-conjugated sheep poly-
clonal antibody to mouse or rabbit IgG (5 mg/ml) did not react
with any peptide.
Identification of AP genes. Both degenerate oligonucleo-
tides SH87 and SH88, representing coding combinations for
H-GADDDDD-OH and H-DDDDDDD-OH, respectively,
detected candidate AP precursor genes in sheep DNA.
Based on this result, SH87 was used as a hybridization probe
to screen a sheep phage genomic library. One million PFU
were screened, and 12 duplicate positives were identified.
Three rounds of purification led to the isolation of two inde-
pendent phage whose genomic DNA inserts contained se-
quences encoding the H-GADDDDD-OH sequence. The pep-
tides encoded are referred to as AP 87-7 and AP 87-8 (Fig. 3),
and their predicted open reading frames (ORF) show distinct
sequences surrounding the heptapeptide codons. AP 87-8 is
unique in encoding variable-length repeats of combinations of
glycine, alanine, and aspartic acid.
PCR-generated probes specific for the putative AP 87-7 and
AP 87-8 coding sequences (see Fig. 3) hybridized strongly to
genomic ovine DNA blots. Using these same probes against a
Northern blot of parenchymal lung RNA obtained from adult
and 4-day-old sheep, we were unable to detect a hybridization
signal (data not shown).
Detection of AP in BAL fluid. AP in BAL fluid or a pulmo-
nary surfactant could be detected with a direct ELISA. As a
positive control, H-DDDDDDD-OH was added to an ELISA-
negative surfactant. The peptide could be detected with anti-
body PAB96-1 or antibody 1G9-1C2 in a linear relationship
(correlation coefficient, 0.995; slope, 0.370). With antibody
1G9-1C2, BAL fluid contained 0.83 6 0.33 mM AP (mean 6
SD; range, 0.10 to 1.59 mM). Results were similar with anti-
body PAB96-1 (data not shown).
BAL fluids varied greatly in antimicrobial activity, ranging
from 0.0 to 98.0% killing.
To confirm that AP was the molecule detected by ELISA
and was responsible for the antimicrobial activity of the BAL
fluids, BAL fluid was separated by RP-HPLC, and fractions
were again tested for antimicrobial activity and were tested for
the presence of AP by competitive ELISA and MALDI mass
spectroscopy. RP-HPLC fraction 5, eluted with 13 to 14%
acetonitrile (Fig. 4A), induced killing of P. haemolytica. This
fraction was also positive for AP by competitive ELISA and
contained H-DDDDDDD-OH [(M 1 H)1; 824.4 Da] and
H-GDDDDDD-OH [(M 1 H)1; 766.1 Da].
FIG. 5. Western blot of ovine tracheal epithelium and lung homogenate.
Lane 1, protein ladder (10 to 200 kDa) standard; lane 2, tracheal-cell homoge-
nate stained with Coomassie blue; lane 3, tracheal-cell homogenate probed with
antibody PAB96-1; lane 4, lung homogenate probed with antibody PAB96-1;
lane 5, lung homogenate stained with Coomassie blue; lane 6, protein ladder
standard. In tracheal epithelial cells, antibody PAB96-1 identified four bands
with molecular masses of 53.7, 31.2, 28.0, and 25.7 kDa. In the lung, antibody
PAB96-1 identified five bands with molecular masses of 53.5, 37.1, 31.2, 28.0, and
25.7 kDa. Identical results were seen with antibody 1G9-1C2 (data not shown).
As controls, strips of membrane containing separated tracheal and lung proteins
were incubated with preimmunized rabbit serum (1:200), preimmunized mouse
serum (1:200), or peroxidase-labeled goat anti-rabbit IgG (0.5 mg/ml) or goat
anti-mouse IgG (0.5 mg/ml). No reactions were seen (data not shown). In addi-
tion, preincubation of antibody PAB96-1 (5 mg/ml) or 1G9-1C2 (5 mg/ml) with
1.0 mM H-DDDDDDD-OH eliminated specific staining of all bands (data not
shown). Blots were photographed (digital camera RD-175; Minolta), and the
sizes of the reactive bands were determined (GelCompar, v. 4.0; Applied Maths)
by extrapolation from a standard curve of the sizes of the stained bands on the
protein ladder.
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Detection of AP in epithelial tissue. AP was also present in
epithelial-cell extracts (Fig. 4B). RP-HPLC fraction 5 induced
killing of P. haemolytica. Although AP could not be detected by
competitive ELISA, this fraction contained H-DDDDDD
D-OH [(M 1 H)1; 824.4 Da] and H-GDDDDDD-OH [(M 1
H)1; 766.1 Da].
Antibodies PAB96-1 and 1G9-1C2 recognized four bands in
blots of solubilized tracheal cells (molecular masses, 53.7, 31.2,
28.0, and 25.7 kDa) and five bands in blots of lung homoge-
nates (molecular masses, 53.5, 37.1, 31.2, 28.0, and 25.7 kDa)
(Fig. 5). Only a weakly staining band was seen in blots of liver
and small-intestine homogenates. No bands were seen in blots
of ovine BAL fluid, albumin, kidney, or spleen homogenates.
The majority of lung tissues collected from the slaughter-
house were normal, but a few had extensive inflammatory cell
infiltration. In general, lesions consisted of infiltrates of lym-
phocytes and plasma cells that had features resembling those
of ovine mycoplasmosis. No distinction was made between
these two groups in this study, and no apparent differences in
results were seen.
Both antibodies PAB96-1 and 1G9-1C2 identified accumu-
lated protein in the apical cytoplasm of the bronchial and
bronchiolar epithelia and in the cytoplasm of pulmonary en-
dothelial cells and an occasional alveolar macrophage (Fig. 6).
Goblet cells and epithelial cells of pulmonary alveoli were not
stained. Both antibodies also reacted with the nuclear regions
FIG. 6. Tissue sections of ovine lung, incubated with antibody 1G9-1C2, show immunocytochemically stained regions of the alveoli (A) and bronchial epithelium
(B) that were not seen in these regions when tissue sections were incubated in secondary antiserum alone (data not shown). Antibody 1G9-1C2 identified accumulated
protein (arrows) in the cytoplasm of pulmonary endothelial cells and an occasional alveolar macrophage (A) and in the apical cytoplasm of the bronchial and
bronchiolar epithelia (B). Goblet cells and epithelial cells of pulmonary alveoli were not stained.
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of many cell types. The nuclei of some bronchial and bron-
chiolar epithelia were brightly stained (Fig. 6B), whereas the
nuclei of other cell types varied in intensity and number. These
included nuclei of cells from submucosal glands of bronchi,
serous cells, endothelial cells, smooth-muscle cells, alveolar
macrophages, and alveolar septal cells. Control tissue sections
were incubated without antibody 1G9-1C2 or with antibody
1G9-1C2 preincubated with 0.5 mM H-DDDDDDD-OH. In
both of these controls, staining specific for AP could not be
detected (data not shown).
DISCUSSION
Antibodies specific to the C-terminal aspartic acid region of
the synthetic peptide H-DDDDDDD-OH demonstrated the
presence of AP in BAL fluids (by ELISA) and related epitopes
in pulmonary tissues (by Western blot and immunocytochem-
istry). The specificity of these antibodies was confirmed by
fractionating BAL fluid and epithelial-cell extracts by RP-
HPLC and demonstrating the presence of H-DDDDDDD-OH
or H-GDDDDDD-OH by MALDI mass spectrometry. AP,
but not the larger precursor proteins, was found in BAL fluid,
and both AP and the larger precursor proteins were found in
epithelial-cell extracts.
While the origin of the AP is not yet known, a number of
observations are consistent with the hypothesis that they are
derived from precursor protein(s), paralleling the biosynthetic
pathway for the cationic antimicrobial peptides (3). First, an-
tibodies to AP recognize several larger proteins (25.7 to 53.7
kDa) in Western blots of solubilized tracheal epithelial cells
and lung homogenates (Fig. 5). Second, a degenerate oligonu-
cleotide probe of AP used to probe a Southern blot of sheep
DNA identified strong hybridizing bands, all ,4 kb, also sug-
gesting that H-DDDDDDD-OH is part of a much larger gene
product (Fig. 3). Third, the amino acid sequences of AP are
similar to those of charge-neutralizing activation peptides of
Group I serine proteases (e.g., human trypsinogen activation
peptide, H-VDDDDK-OH) and contain homopolymeric re-
gions of Asp following a Gly or Ala and terminating with Lys.
Synthetic trypsinogen activation peptide and other similar frag-
ments have antimicrobial activity (4).
A number of AP-related sequences have been found in other
cellular and nuclear proteins (e.g., human B23 nucleophosmin,
containing the internal sequence DEDDDDDDEEDDDED
DDDDD [GenBank accession no. X16934]). Staining of the
latter protein may help explain the epithelial-cell nuclear stain-
ing we detected. However, no DNA/protein sequences encod-
ing the heptapeptide AP have been reported in sheep or in
other animal species.
Innate immune mechanisms serve to suppress or reduce
microbial growth at multiple epithelial surfaces. In the respi-
ratory tract, AP can be demonstrated readily both in respira-
tory epithelium and in mucosal secretions at concentrations
that are antimicrobial. These findings support the hypothesis
that AP not only contribute to the microenvironment on alve-
olar surfaces but also function as an adjunct to the well-char-
acterized peptide and cellular host defense elements of the
mammalian airway. Experiments designed to test this hypoth-
esis in animal models of pneumonia are in progress.
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